NEW! Subscribe to Medtech Pro and get one or all of our reports, plus much more.

International Markets for Specialty Peripheral Vascular Products

85 Pages | 41 Exhibits | Forecasts Through 2019
market-report-samples/GlobalMarketSegments2.jpg market-report-samples/GlobalMarketSegments3caps.jpg market-report-samples/GlobalMarketSegmentsCaps.jpg
Buy Now

Overview

The international market for atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices was valued at $733 million during 2013. This new report from Life Science Intelligence explores the market for these devices in Europe, Asia-Pacific and the rest of the world and analyzes key factors influencing the international market, such as how clinical studies in support of product approvals in the U.S. could affect uptake and utilization in Europe; the effects of drug-coated balloons (DCBs) on the interventional market; economic conditions and cost-containment initiatives; and clinical efforts to optimize therapeutic interventions.

Critical Issues Covered in this Report:
•    Quantitative factors including units, pricing, and product sales;
•    The competitive landscape for these devices in international markets; and
•    Procedure volumes as well as other key infrastructure and market metrics.

Table of Contents

1. EXECUTIVE SUMMARY
 
1.1 The International Market by Product Type 
1.2 The International Market by Region 
1.2.1 Europe 
1.2.2 Asia-Pacific and the Rest-of-the-World 
1.3 Competitive Analysis 

Exhibit 1-1: Specialty Peripheral Vascular Procedures in OUS Markets from 2012-2019  
Exhibit 1-2: The OUS Market Forecast for Atherectomy Products, Balloon Catheters, Chronic Total Occlusion Devices, and Embolic Protection Devices from 2012-2019  
Exhibit 1-3: The European Market Forecast for Atherectomy Products, Balloon Catheters, Chronic Total Occlusion Devices, and Embolic Protection Devices from 2012-2019  
Exhibit 1-4: The AP & ROW Market Forecast for Specialty Peripheral Vascular Products by Type, 2012-2019 
Exhibit 1-5: OUS Supplier Shares in 2012 and 2013 

2. OVERVIEW
 
2.1 The Circulatory System 
2.2 Vascular Anatomy and Physiology 
2.2.1 Peripheral Arteries 
2.2.2 Coronary Arteries 
2.2.3 Arteries of the Head and Neck 
2.3 Vessel Tissues and Structures 
2.4 Peripheral Vascular Disease 
2.5 Prevalence of PAD by Region 
2.5.1 The United States 
2.5.2 Europe 
2.5.3 Asia-Pacific and the Rest of the World 

Exhibit 2-1: Overview of the Circulatory System 
Exhibit 2-2: Major Arteries in the Cardiovascular System 
Exhibit 2-3: Types and Functions of the Blood Vessels 
Exhibit 2-4: Peripheral Arteries and Arteries of the Lower Extremity 
Exhibit 2-5: Arteries of the Hand, Including the Radial Artery 
Exhibit 2-6: Arteries of the Head and Neck 
Exhibit 2-7: Anatomy of the Arteries and Veins 
Exhibit 2-8: Prevalence of Peripheral Artery Disease in the U.S. 
Exhibit 2-9: Prevalence of Peripheral Artery Disease in Europe 
Exhibit 2-10:  Prevalence of Peripheral Artery Disease in AP & ROW Countries 

3. SPECIALTY PERIPHERAL VASCULAR PRODUCTS
 
3.1 Atherectomy Technologies 
3.2 Balloon Catheters 
3.3 Chronic Total Occlusion Devices 
3.4 Embolic Protection Systems

Exhibit 3-1: Specialty Peripheral Vascular Products by Type 
Exhibit 3-2: Selected Recent Studies of Atherectomy for Peripheral Artery Disease   
Exhibit 3-3: Atherectomy Devices: Selected Products and Suppliers in 2014 
Exhibit 3-4: Selected Recent Studies of Balloon Angioplasty for Peripheral Artery Disease  
Exhibit 3-5: Balloon Catheters: Selected Products and Suppliers in 2014 
Exhibit 3-6: Selected Recent Studies of Devices Used for Peripheral Artery Chronic Total Occlusion 
Exhibit 3-7: Devices for Chronic Total Occlusion: Selected Products and Suppliers in 2014  
Exhibit 3-8: Selected Recent Studies of Devices Used for Embolic Protection during Peripheral Artery Procedures 
Exhibit 3-9: Embolic Protection Devices: Selected Products and Suppliers in 2014   

4. PROCEDURE FORECASTS & MARKET ANALYSIS
 
4.1 The European Market Forecast for Specialty Peripheral Vascular Products 
4.1.1 Atherectomy Products 
4.1.2 Balloon Catheters 
4.1.3 Chronic Total Occlusion Devices 
4.1.4 Embolic Protection Devices 
4.2 The AP & ROW Market Forecast for Specialty Peripheral Vascular Products 
4.2.1 Atherectomy Products 
4.2.2 Balloon Catheters 
4.2.3 Chronic Total Occlusion Devices 
4.2.4 Embolic Protection Devices 
4.3 Competitive Analysis 

Exhibit 4-1: The OUS Market Forecast for Specialty Peripheral Vascular Products by Type, 2012-2019 
Exhibit 4-2: The OUS Market Forecast for Specialty Peripheral Vascular Products by Region, 2012-2019 
Exhibit 4-3: The European Market Forecast for Specialty Peripheral Vascular Products by Type, 2012-2019 
Exhibit 4-4: The European Market Forecast for Atherectomy Products from 2012-2019  
Exhibit 4-5: The European Market Forecast for Atherectomy Devices by Type in 2012, 2013, and 2014 
Exhibit 4-6: The European Market Forecast for Balloon Catheters from 2012-2019   
Exhibit 4-7: The European Market Forecast for Balloon Catheters by Type from 2012-2019  
Exhibit 4-8: The European Market Forecast for Chronic Total Occlusion Devices from 2012-2019 
Exhibit 4-9: The European Market Forecast for Embolic Protection Devices from 2012-2019  
Exhibit 4-10: The European Market Forecast for Embolic Protection Devices by Type from 2012-2019 
Exhibit 4-11: The AP & ROW Market Forecast for Specialty Peripheral Vascular Products by Type, 2012-2019 
Exhibit 4-12: The AP & ROW Market Forecast for Atherectomy Products from 2012-2019  
Exhibit 4-13: The AP & ROW Market Forecast for Atherectomy Devices by Type in 2012, 2013, and 2014 
Exhibit 4-14: The AP & ROW Market Forecast for Balloon Catheters from 2012-2019  
Exhibit 4-15: The AP & ROW Market Forecast for Chronic Total Occlusion Devices from 2012-2019  
Exhibit 4-16: The AP & ROW Market Forecast for Embolic Protection Devices from 2012-2019  
Exhibit 4-17: The AP & ROW Market Forecast for Embolic Protection Devices by Type from 2012-2019                  

5. COMPANY PROFILES
 
5.1 Abbott Vascular (Abbott) 
5.2 Bard Peripheral Vascular (C.R. Bard) 
5.3 Boston Scientific 
5.4 Cook Medical (Cook Group) 
5.5 Cordis Corporation (Johnson & Johnson) 
5.6 Covidien 
5.7 Medtronic 
5.8 Straub Medical
5.9 W.L. Gore and Associates 

Companies Covered

Aachen Resonance
Abbott Vascular (Abbott)
AccessClosure
AngioScore
Angioslide
Avinger
B. Braun
Bard Peripheral Vascular (C.R. Bard)
Bayer Interventional
Baylis Medical
Biotronik
Boston Scientific
Cardiovascular Systems
Cook Medical (Cook Group)
Cordis Corporation (Johnson & Johnson)
Covidien
Eurocor
Medtronic
Minvasys
Natec Medical
Spectranetics
Straub Medical
Teleflex Medical
Terumo Interventional Systems
Trireme Medical
Vascular Solutions
Volcano
W.L. Gore and Associates